The field of currently claimed embodiments of this invention relates to porous materials, and more particularly to non-covalent π⋅⋅⋅π-Interaction-constructed organic frameworks (πOFs) and use in photo-electronics, detection and drug and bioactive agent delivery applications.
Ordered microporous materials have aroused extensive interest due to their outstanding performance and numerous existing and potential applications, such as gas storage and separation, heterogeneous catalysis, drug release and proton conduction. The important families of microporous crystalline materials include covalent organic frameworks (COFs), held together by strong covalent bonds, metal-organic frameworks (MOFs) linked via strong coordination bonds and hydrogen-bonded organic frameworks (HOFs) connected through weak hydrogen bonding, all of which have been developed over the past decade. These microporous materials not only expanded the concept of molecular architectures but also offer extensive applications that serve as an inspiration to explore novel multifunctional materials. However, among the numerous applications, integration of organic frameworks into organic electronics, such as organic field-effect transistors (OFET), organic light-emitting diodes (OLED) and solar cells, has been challenging due to poor electrical conductivity and solubility through coordination, covalent and hydrogen bonds.
Therefore, there remains a need for improved electronic and photonic materials among other applications. The following describes a novel material that can be used in many photo-electronics and detection applications, for example.
An embodiment of the present invention is directed to a composition that includes a pi-pi interaction-constructed organic framework (pi-OF) and a bioactive agent absorbed into said pi-OF. The pi-OF includes a plurality of molecular structures, each molecular structure including a centroid core having two spirobifluorene (SF) units, the two SF units forming a rigid biplanar conjugated cruciform-shaped spirobifluorene, the two SF units forming an essentially orthogonal configuration; and a plurality of multijoint fragment units, each unit including a 3-(dicyanomethylidene)indan-1-one (IC) unit, each IC unit is used as an end group (EG) to each end of the two spirobifluorene (SF) units. Each IC unit is configured to interact via a pi-pi interaction with a neighboring IC unit of an adjacent molecular structure or to interact via a CH-interaction with neighboring aromatic group (R1) of an adjacent molecular structure, or both.
Another embodiment of the present invention is directed to a method of administering a bioactive agent to an animal or a human that includes injecting the composition of the paragraph above into the animal or human and illuminating the composition after the injecting with light to cause at least a portion of the bioactive agent to be released in response to the illuminating.
Another embodiment of the present invention is directed to a molecular structure (SFIC) that includes a centroid core having two spirobifluorene (SF) units, the two SF units forming a rigid biplanar conjugated cruciform-shaped spirobifluorene, the two SF units forming an essentially orthogonal configuration, and a plurality of multijoint fragment units, each unit comprising a 3-(dicyanomethylidene)indan-1-one (IC) unit, each IC unit is used as an end group (EG) to each end of the two spirobifluorene (SF) units. Each IC unit is configured to interact via a pi-pi interaction with a neighboring IC unit of an adjacent molecular structure or to interact via a CH-interaction with neighboring aromatic group (R1) of an adjacent molecular structure, or both.
Another embodiment of the present invention is directed to a pi-pi interaction-constructed organic framework (pi-OF) that includes a plurality of molecular structures, each molecular structure including a centroid core having two spirobifluorene (SF) units, the two SF units forming a rigid biplanar conjugated cruciform-shaped spirobifluorene, the two SF units forming an essentially orthogonal configuration; and a plurality of multijoint fragment units, each unit comprising a 3-(dicyanomethylidene)indan-1-one (IC) unit, each IC unit is used as an end group (EG) to each end of the two spirobifluorene (SF) units. Each IC unit is configured to interact via a pi-pi interaction with a neighboring IC unit of an adjacent molecular structure or to interact via a CH-interaction with neighboring aromatic group (R1) of an adjacent molecular structure, or both.
Another embodiment of the present invention is directed to a transistor device that includes a substrate; a plurality of electrodes disposed on the substrate; and a SFIC microplate. The SFIC microplate includes a molecular structure that includes a centroid core having two spirobifluorene (SF) units, the two SF units forming a rigid biplanar conjugated cruciform-shaped spirobifluorene, the two SF units forming an essentially orthogonal configuration; and a plurality of multijoint fragment units, each unit comprising a 3-(dicyanomethylidene)indan-1-one (IC) unit, each IC unit is used as an end group (EG) to each end of the two spirobifluorene (SF) units. Each IC unit is configured to interact via a pi-pi interaction with a neighboring IC unit of an adjacent molecular structure or to interact via a CH-interaction with neighboring aromatic group (R1) of an adjacent molecular structure, or both. The SFIC microplate is disposed on the plurality of electrodes.
Another embodiment of the present invention is directed to an organic light emitting device that includes a substrate electrode; an electron transport layer and a hole transport layer disposed on the substrate electrode; and a SFIC layer sandwiched between the electron transport layer and the hole transport layer. The SFIC layer has a molecular structure that includes a centroid core having two spirobifluorene (SF) units, the two SF units forming a rigid biplanar conjugated cruciform-shaped spirobifluorene, the two SF units forming an essentially orthogonal configuration; and a plurality of multijoint fragment units, each unit comprising a 3-(dicyanomethylidene)indan-1-one (IC) unit, each IC unit is used as an end group (EG) to each end of the two spirobifluorene (SF) units. Each IC unit is configured to interact via a pi-pi interaction with a neighboring IC unit of an adjacent molecular structure or to interact via a CH-interaction with neighboring aromatic group (R1) of an adjacent molecular structure, or both.
The present disclosure, as well as the methods of operation and functions of the related elements of structure and the combination of parts and economies of manufacture, will become more apparent upon consideration of the following description and the appended claims with reference to the accompanying drawings, all of which form a part of this specification, wherein like reference numerals designate corresponding parts in the various figures. It is to be expressly understood, however, that the drawings are for the purpose of illustration and description only and are not intended as a definition of the limits of the invention. As used in the specification and in the claims, the singular form of “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise.
FIG. SE shows hole and electron transfer integral distributions in all transport directions, according to an embodiment of the present invention;
Some embodiments of the current invention are discussed in detail below. In describing embodiments, specific terminology is employed for the sake of clarity. However, the invention is not intended to be limited to the specific terminology so selected. A person skilled in the relevant art will recognize that other equivalent components can be employed and other methods developed without departing from the broad concepts of the current invention. All references cited anywhere in this specification, including the Background and detailed description sections, are incorporated by reference as if each had been individually incorporated.
The term “substrate” is intended to have a broad meaning that can include a single layer of a material, multiple layers, laminated layers, composite layers, flexible structures, rigid structures, organic materials, inorganic materials, or combinations thereof. For example, and without limitation, substrates can be glass, plastic, or crystalline materials (e.g., silicon or another semiconductor).
In the present description the term “pi” is sometimes used instead of the Greek letter “π”. However, as understood by one of ordinary skill in the art, they are equivalent. For example, “π⋅⋅⋅π interaction” and “pi-pi interaction” are equivalent. Similarly, “pi-OF” and “πOF” are also equivalent.
Transport along π⋅⋅⋅π interactions in the 2D in-plane direction, on the other hand, is considered to be a key transport mechanism in organic semiconductors, laying the foundation for remarkable device performance. Therefore, π⋅⋅⋅π interaction-constructed porous materials with an ordered structure is of special interest. However, due to the inherent features of π⋅⋅⋅π interaction (weak, flexible and poor directionality), construction of porous material with a permanent porosity is a difficult task, as the structure will most likely easily collapse after solvent removal and decompose upon heating. We are unaware of a previous porous material held together by π⋅⋅⋅π interactions.
An aspect of the present invention is to provide a molecular structure SFIC The molecular structure SFIC includes a centroid core having two spirobifluorene (SF) units, the two SF units forming a rigid biplanar conjugated cruciform-shaped spirobifluorene, the two SF units forming an essentially orthogonal configuration; and a plurality of multijoint fragment units, each fragment unit comprising a 3-(dicyanomethylidene)indan-1-one (IC) unit, each IC unit is used as an end group (EG) to each end of the two spirobifluorene (SF) units. Each IC unit is configured to interact via a pi-pi interaction (π⋅⋅⋅π interaction) with a neighboring IC unit of an adjacent molecular structure or to interact via a CH-interaction with neighboring aromatic group (R1) of an adjacent molecular structure, or both.
In an embodiment, the biplanar conjugated cruciform-shaped spirobifluorene forms a rigid three-dimensional structure. In an embodiment, each SF unit has a spiro-conjugated structure acting as a tetrahedral node. In an embodiment, the SFIC molecular structure further includes thiophene units provided to increase the pi-conjugated plane of each SF unit. In an embodiment, each IC unit is a chromophore configured to absorb or emit radiation.
In an embodiment, the molecular structure (SFIC) exhibits a tetragonal-disphenoid-shaped molecular conformation and is configured to self-assemble into a 3D porous structure. In an embodiment, the molecular structure (SFIC) has thermal stability after heat treatment. In an embodiment, the molecular structure (SFIC) is recyclable.
In an embodiment, the two SF units forming a rigid biplanar conjugated cruciform-shaped spirobifluorene include:
wherein R1 is an aromatic group.
In an embodiment, R1 is selected from the group consisting of:
wherein R2 is an alkyl chain.
In an embodiment, the two SF units forming a rigid biplanar conjugated cruciform-shaped spirobifluorene are selected from the group consisting of:
In an embodiment, each IC unit end group (EG) is selected from the group consisting of:
Another aspect of the present invention is to provide a non-covalent pi-pi interaction-constructed organic framework (pi-OF). The non-covalent pi-pi interaction-constructed organic framework (pi-OF) includes a plurality of molecular structures. Each molecular structure includes a centroid core having two spirobifluorene (SF) units, the two SF units forming a rigid biplanar conjugated cruciform-shaped spirobifluorene, the two SF units forming an essentially orthogonal configuration; and a plurality of multijoint fragment units, each unit comprising a 3-(dicyanomethylidene)indan-1-one (IC) unit, each IC unit is used as an end group (EG) to each end of the two spirobifluorene (SF) units. Each IC unit is configured to interact via a pi-pi interaction with a neighboring IC unit of an adjacent molecular structure or to interact via a CH-interaction with neighboring aromatic group (R1) of an adjacent molecular structure, or both.
In an embodiment, the biplanar conjugated cruciform-shaped spirobifluorene forms a rigid three-dimensional structure. In an embodiment, the SF has a spiro-conjugated structure acting as a tetrahedral node. In an embodiment, the non-covalent pi-pi interaction-constructed organic framework (pi-OF) further includes thiophene units to increase the pi-conjugated plane of each SF unit. In an embodiment, each IC unit is a chromophore configured to absorb or emit radiation. In an embodiment, the molecular structure exhibits a tetragonal-disphenoid-shaped molecular conformation and configured to self-assemble into a 3D porous structure. In an embodiment, each molecular structure has thermal stability after heat treatment.
In an embodiment, each molecular structure is connected to four adjacent molecular structures. In an embodiment, the adjacent molecular structures are rotated by 90 degrees relative to the each molecular structure. In an embodiment, each molecular structure is connected to four adjacent molecular structures through four pairs of π⋅⋅⋅π interactions through antiparallel EGs.
In an embodiment, the organic framework forms a final three-dimensional lamellar structure In an embodiment, the non-covalent pi-pi interaction-constructed organic framework (pi-OF) has a plurality of 2D layers, wherein an orientation of molecular structures of adjacent 2D layers are identical and assemble into two repeating layers.
In an embodiment, the pi-OF framework forms a porous 3D structure that is held together by π⋅⋅⋅π interactions and further enhanced by intermolecular CH⋅⋅⋅π interactions. In an embodiment, the pi-OF framework can be used in organic field effect transistors (OFET), organic light-emitting diodes (OLED), solar cells or sensors. In an embodiment, the pi-OF can be used as a photoresist in the semiconductor photolithographic process, self-assembly into various shapes or patterns for patterning of metal circuits or semiconductors.
Another aspect of the present invention is to provide a transistor device including a substrate, a plurality of electrodes disposed on the substrate; and a SFIC micro-plate. The SFIC micro-plate has a molecular structure including a centroid core having two spirobifluorene (SF) units, the two SF units forming a rigid biplanar conjugated cruciform-shaped spirobifluorene, the two SF units forming an essentially orthogonal configuration; and a plurality of multijoint fragment units. each unit comprising a 3-(dicyanomethylidene)indan-1-one (IC) unit, each IC unit is used as an end group (EG) to each end of the two spirobifluorene (SF) units. Each IC unit is configured to interact via a pi-pi interaction with a neighboring IC unit of an adjacent molecular structure or to interact via a CH-interaction with neighboring aromatic group (R1) of an adjacent molecular structure, or both. The SFIC microplate is disposed on the plurality of electrodes.
In an embodiment, the plurality of electrodes include four electrodes disposed in a quadrangular arrangement, wherein the SFIC microplate is in contact with each of the four electrodes.
A further aspect of the present invention is to provide an organic light emitting device including a substrate electrode; an electron transport layer (ETL) and a hole transport layer (HTL) disposed on the substrate electrode; and a SFIC layer sandwiched between the electron transport layer and the hole transport layer. The SFIC layer has a molecular structure including a centroid core having two spirobifluorene (SF) units, the two SF units forming a rigid biplanar conjugated cruciform-shaped spirobifluorene, the two SF units forming an essentially orthogonal configuration; and a plurality of multijoint fragment units, each unit comprising a 3-(dicyanomethylidene)indan-1-one (IC) unit, each IC unit is used as an end group (EG) to each end of the two spirobifluorene (SF) units. Each IC unit is configured to interact via a pi-pi interaction with a neighboring IC unit of an adjacent molecular structure or to interact via a CH-interaction with neighboring aromatic group (R1) of an adjacent molecular structure, or both.
In an embodiment, the substrate includes indium titanium oxide (ITO) glass. In aembodiment, the electron transport layer comprises ZnMgO. The electron transport layer can be deposited on the substrate electrode. In an embodiment, hole transport layer comprises 4,4′-bis (9-carbazolyl) biphenyl (CBP). The hole transport layer can be deposited on the SFIC layer.
In an embodiment, the organic emitting device further includes a second electrode, the second electrode being deposited on the hole transport layer. In an embodiment, the second electrode includes a layer of gold (Au).
In an embodiment, the organic emitting device further includes an intermediate layer disposed between the second electrode and the hole transport layer. In an embodiment. the intermediate layer may include molybdenum oxide (MoO3).
Further Examples: New supermolecular organic porous crystal materials developed by our group.
We reported a novel robust noncovalent π⋅⋅⋅π-interaction-constructed organic framework, namely πOF, consisting of a permanent 3D porous structure that is held together by noncovalent π⋅⋅⋅π interactions and further enhanced by intermolecular CH⋅⋅⋅π interactions (Proc. Natl. Acad. Sci. U S A (PNAS), 2020, 117, 20397-20403.; Adv. Mater., 2021, 33, 2006120.). In some embodiments, the elaborate porous structure consists of only one type of fully conjugated aromatic tetragonal-disphenoid-shaped molecule with four identical 3-(dicyanomethylidene)indan-1-one planforms. Essentially, our robust noncovalent π⋅⋅⋅π interaction-stacked organic framework is composed of 3-(dicyanomethylidene)indan-1-one (IC) functional group with directional face-on packing as a multijoint fragment and spirobifluorene (SF) as the centroid core (
3D structural characterizations: XRD analysis of single crystals indicated that the dimensions of SFIC conformers are ˜21.92 Å in length, ˜19.13 Å in width, and ˜14.28 Å in height (
In an embodiment, a target product SFIC was obtained via Knoevenagel condensation between SF-CHO and 3-(dicyanomethylidene)indan-1-one (IC) in 90% yield (
Self-healing materials have received tremendous attention recently. However, in the case of solid materials, presence of notable healing properties often results in low thermostability. SFIC πOF, on the contrary, showed excellent thermal stability with decomposition temperature of over 351° C. with a 5% weight loss. After heat-treatment at 240° C., πOF self-healed retrieving its parent porosity upon solvent annealing (methanol/chloroform vapor) at room temperature (
To evaluate the intrinsic charge transport properties of πOF, the single-crystal micro-plates of SFIC were prepared by a typical drop-casting method in CHCl3 solution onto the noctadecyltrichlorosilane (OTS) modified SiO2/Si substrates Optical microscope (OM) images and bright-field TEM images (top-left inset) of the SFIC micro-plates with a rhomboid shape and long-range regularity are presented in
To elucidate the correlation between single crystal and the packing orientation of the film, the single crystal data and the two-dimensional grazing incidence wide-angle X-ray scattering (2DGIWAXS) analysis are compared in
We also were able to fabricate OLEDs with SFIC used as an emitter as shown in
We performed extensive theoretical calculations for the computational characterization of hole/electron transport in SFIC. To be parallel to
Materials and Methods: ZnMgO dispersion was purchased from Suzhou ever display advanced materials Co., Ltd. CBP was purchased from Lumtec Company. All other chemicals and solvents were purchased from commercial suppliers and used without further purification unless otherwise specified. 1H NMR (400 MHz or 500 MHz) and 13C NMR (125 MHz) spectra were recorded in deuterated solvents on a Bruker ADVANCE 500 or 400 NMR spectrometer. J values are expressed in Hz and quoted chemical shifts are in ppm. The signals have been designated as follows: s (singlet), d (doublet), t (triplet), q (quartet), sd (singlet doublet), dd (doublet doublet) and m (multiplet). High resolution mass spectra (HRMS) were determined on IonSpec 4.7 Tesla Fourier Transform Mass Spectrometer. UV-Vis absorption spectra of the film and solution were obtained using a U-4100 spectrophotometer (Hitachi) equipped with integrating sphere, in which monochromatic light was incident to the substrate side and solution in a 1−cm quartz cell. Cyclic voltammograms (CVs) were recorded on an Epsilon electrochemical workstation using glassy carbon discs as the working electrode, Pt wire as the counter electrode, Ag/AgCl electrode as the reference electrode at a scanning rate of 100 mV/s. 0.1 M tetrabutylammoniumhexafluorophosphate (Bu4NPF6) dissolved in CH3CN was used as the supporting electrolyte. The microscope images of all the micro-/nanocrystals were acquired by an optical microscope (Vision Engineering Co., UK), which was coupled to a CCD camera. Grazing incident wide angle X-ray scattering (GIWAXS) measurement was performed at Advanced Light Source on the 7.3.3. beamline. All the samples were deposited on the silicon wafer with 100 nm silicon oxide. Samples were irradiated by 10 KeV at a fixed X-ray incident angle of 0.18° with an exposure time of 10 s, the wavelength of incident X-ray is 0.124 nm. Transmission electron microscopy (TEM) was carried out on a JEM 2100 LaB6 at 200 kV. The energy-dispersive X-ray analysis (EDS) and HRTEM images were recorded on a Tecnai F20 transmission electron microscopy under a working voltage of 200 kV. The X-ray diffraction (XRD) data were carried out on a Bruker D8-advance X-ray power diffractometer with Cu-Kα radiation (α=1.5406 Å). N2 adsorption-desorption isotherms were obtained on a Micromeritics ASAP 2460 analyzer (USA) at liquid nitrogen temperature (77 K). The samples were degassed in a vacuum at 80° C. for 6 h prior to the measurement. Pore size distributions were estimated using non-local density functional theory (NLDFT) and BJH (Barret-Joyner-Halenda) model. The surface areas were calculated by the BET (Brunauer-Emmett-Teller) method. The CO2 sorption isotherms were measured by an automatic adsorption equipment (Autosorb-iQ-MP).
The reaction conditions were (i) Methyl 2-bromothiophene-3-carboxylate (4.5 equiv.), 2,2′,7,7′-tetrakis(pinacolatoboryl)-9,9′-Spirobi[9H-fluorene] (1.0 equiv), Pd(PPh3)4 (0.3 equiv), K2CO3 (2M)/THF (1:2), 95° C., 72 h. Yield: 80%. (ii) 1-bromo-4-hexylbenzene (22 equiv.), magnesium turnings (26.4 equiv.), THF, RT to 70° C., 20 h. Yield: 85%. (iii) Boron trifluoride diethyl etherate (diluted by chloroform), chloroform, 70° C., 24h. Yield: 75%. (iv) DMF, POCl3, 0° C. to 90° C., 20 h. Yield: 70%. (v) 2-(3-oxo-2,3-dihydro-1H-inden-1-ylidene) malononitrile (12 equiv.), pyridine (1 ml), chloroform, 70° C., Yield: 90%.
Compound 1: A Schlenk flask was charged with 2,2′,7,7′-tetrakis(pinacolatoboryl)-9,9′-Spirobi[9H-fluorene] (500 mg, 0.61 mmol, 1.0 equiv), Methyl 2-bromothiophene-3-carboxylate(606 mg, 2.74 mmol, 4.5 equiv), THF (6 ml) and K2CO3 aqueous solution (2M, 3 ml). The mixture was degassed with argon for 15 min. Pd(PPh3)4 (211 mg, 0.183 mmol, 0.3 equiv) was added under an argon atmosphere. The mixture was refluxed for 72 h and then cooled to room temperature. 50 mL of water was added and the mixture was extracted with dichloromethane (3×50 mL). The organic phase was dried over anhydrous MgSO4. After removing the solvent, the residue was purified by column chromatography on silica gel, eluted with Hexane/CH2Cl2 (1:5 v/v) to afford the compound 1 (428 mg, 80% yield) as a pale yellow solid.
1H NMR (400 MHz, CDCl3, 298.5 K) δ=7.90-7.88 (dd, J1=0.36 Hz, J2=7.92 Hz, 4 H), 7.57-7.55 (dd, J1=1.68 Hz, J2=7.92 Hz, 4 H), 7.42-7.40 (d, J=5.36 Hz, 4 H), 7.16-7.14 (d, J=5.36 Hz, 4 H), 6.96-6.95 (sd, J=1.16 Hz, 4 H), 3.27 (s, 12 H).
Compound 2: A Grignard reagent was freshly prepared by reacting 1-bromo-4-hexylbenzene (3.395 g, 14.475 mmol, 22 equiv) with magnesium turnings (410 mg, 16.975 mmol, 26.4 equiv) in dry THF (13 ml). To a solution of compound 1(600 mg, 0.643 mmol, 1 equiv) in dry THF (30ml) was added dropwise the prepared Grignard regent under the argon at room temperature. The reaction mixture was refluxed at 70° C. for 20 h and then quenched with water, followed by extraction with diethyl ether (50 mL×3) and water (100 mL). The collected organic layer was dried over MgSO4. After removal of the solvent under reduced pressure, the crude product was purified by column chromatography on silica gel, eluted with Hexane/CH2Cl2 (1:2 v/v) to afford the compound 2 as colorless oil liquid. (1.12 g, 85% yields).
1H NMR (400 MHz, CDCl3, 298.5 K) δ=7.52-7.50 (d, J=7.88 Hz, 4 H), 7.11-7.09 (m, 4 H), 6.98-6.96 (m, 4 H), 6.88 (s, 32 H), 6.57 (s, 4 H), 6.33-6.32 (m, 4 H), 2.93 (s, 4 H), 2.55-2.51 (t, J1_=8.16 Hz, J2=7.24 Hz, 16 H), 1.57-1.56 (m, 16 H), 1.33 (s, 48 H), 0.92-0.91 (m, 24 H).
Compound 3: The Compound 2 (1.0 g, 0.489 mmol) was dissolved in 150 ml CHCl3. Then a diluted solution of boron trifluoride diethyl etherate (3 ml) in CHCl3 (50 ml) was added dropwise over a period of 30 min at room temperature. The reaction mixture was stirred at 70° C. for 24 h and then cooled to room temperature. The mixture was extracted with water (3×50 mL). The organic phase was dried over anhydrous MgSO4. After removing the solvent, the residue was purified by column chromatography on silica gel, eluted with Hexane/CH2Cl2 (1:1 v/v) to afford the compound 3 (724 mg, 75% yield) as a yellow sticky solid.
1H NMR (400 MHz, CDCl3, 298.5 K) δ=7.70 (sd, J=0.48 Hz, 4 H), 7.21-7.19 (d, J=8.28 Hz, 16 H), 7.17-7.16 (d, J =4.84 Hz, 4 H), 7.10-7.08 (d, J=8.32 Hz, 16 H), 6.92-6.91 (d, J=4.88 Hz, 4 H), 6.88 (s, 4 H), 2.60-2.56 (t, J1=7.68 Hz, J2=7.96 Hz, 16 H), 1.54-1.50 (m, 16 H), 1.31 (m, 48 H), 0.86 (m, 24 H).
Compound 4: To a cold solution of compound 3 (300 mg, 0.15 mmol) in DMF (30 mL), POCl3 (1 ml) was added dropwise at 0° C. under Ar. After being stirred at 90° C. for 20 h, the mixture was poured into ice water (200 ml), neutralized with NaOH, and then extracted with dichloromethane. The combined organic layer was washed with water and brine and dried over anhydrous MgSO4. After removal of solvent, it was purified using chromatography on silica gel using hexane/dichloromethane (1:1) as eluent, yielding a yellow-colored solid (222 mg, 70%).
1H NMR (400 MHz, CDCl3, 298.5 K) δ=9.75 (s, 4 H), 7.78 (s, 4 H), 7.58 (s, 4 H), 7.18-7.16 (d, J=8.32 Hz, 16 H), 7.13-7.10 (d, J=8.4 Hz, 16 H), 7.00 (s, 4 H), 2.61-2.57 (t, J1=7.92 Hz, J2_7.64 Hz, 16 H), 1.63-1.59 (m, 16 H), 1.36-1.25 (m, 48 H), 0.89-0.87 (m, 24 H).
Compound SFIC: Compound 4 (100 mg, 0.048 mmol, 1 equiv) and 2-(3-oxo-2,3-dihydro-1Hinden-1-ylidene) malononitrile (112 mg, 0.575 mmol, 12 equiv) were dissolved in CHCl3 (35 ml), then pyridine (1 ml) was added under argon. The mixture was then refluxed for 18 h, cooled to room temperature, poured into CH3OH (200 mL) and filtered. The crude product was purified with column chromatography using hexane/dichloromethane (1:1) as eluent to obtain pure SFIC as a black solid (120 mg, 90%).
1H NMR (500 MHz, C2D2Cl4, 373.2 K) δ=8.83 (s, 4 H), 8.68-8.66 (d, J=7.70 Hz, 4 H), 8.04 (s, 4 H), 7.89-7.87 (d, J=7.30 Hz, 4 H), 7.78-7.71 (m, 12 H), 7.31-7.28 (m, 20 H), 7.25-7.23 (d, J=8.25 Hz, 16 H), 2.71-2.68 (t, J1=7.60 Hz, J2=7.90 Hz, 16 H), 1.76-1.70 (m, 16 H), 1.46-1.39 (m, 48 H), 0.96-0 0.94 (t, J1=J2=7.00 Hz, 24 H); 13C NMR (125 MHz, C2D2Cl4, 373.2 K): δ=187.76, 160.52, 158 92, 158.18, 157.09, 149.62, 143.09, 142.01, 140.90, 140.57, 140.02, 139.18, 138.18, 137.08, 136.92, 134.91, 134.26, 128.73, 127.98, 125.14, 123.61, 122.40, 119.06, 117.80, 114.54, 35.54, 31.63, 30.84, 29.08, 22.46, 13.91; HRMS (MALDI(N), 100%): calcd (%) for C193H168N8O4S4: 2789.20769; found, 2789.20576.
X-ray Crystal Structure: The single crystals of SFIC were obtained by slow vapor diffusion method under the CHCl3 (good solvent) and CH3OH (poor solvent). Single crystal data collections were performed on a MM007HF Saturn724+ diffractometer using Cu Ka radiation (1.54184 Å) at about 170 K. Using Olex2, these structures were solved with the ShelXS and refined with the ShelXL-2014 refinement package using the Least Squares minimization. Refinement was performed on F2 anisotropically for all the non-hydrogen atoms by the full-matrix least-squares method. The hydrogen atoms were placed at the calculated positions and were included in the structure calculation without further refinement of the parameters. Because of the very large thermal motion and disorder of solvent molecules in the lattice, the diffuse residual electron density was difficult to model accurately and thus, a treatment by SQUEEZE (from PLATON) was used for solvate molecules in SFIC, which leads to large solvent accessible voids in structures. Despite many attempts, the diffraction intensity peaks of SFIC stayed weak due to insufficient quality of single crystals, which led to their high R values and alerted of level A in checkCIF reports.
Table 1 provides Crystallographic data and structure refinement details for SFIC.
(000)
indicates data missing or illegible when filed
Transistor Device Fabrication and Characterization: The substrates were cleaned first with pure water, then piranha solution (H2SO4/H202=7:3), pure water and finally with pure isopropyl alcohol, and then blown dry with high-purity nitrogen gas. Treatment of the Si/SiO2 wafers with OTS was carried out by the vapor-deposition method. The clean wafers were dried under vacuum at 90° C. for 0.5 h to eliminate moisture. When the temperature decreased to 70° C., a small drop of OTS was placed around the wafers. Subsequently, this system was heated to 120° C. and maintained for 2 h under vacuum. Micro-/nano-crystals were formed using a dilute CHCl3 solution (1 mg mL−1). Bottom-gate top-contact OFETs based on the micro-/nano-crystals were constructed on an OTS modified Si/SiO2 substrate (n-type Si wafer containing 300 nm-thick SiO2) using an “organic ribbon mask” technique. Prior to self-assembly of micro-/nano-crystals, the OTS modified Si/SiO2 substrate was cleaned with pure n-hexane, pure chloroform and pure isopropyl alcohol. Then, micro-/nano-crystals were produced on Si/SiO2 substrates through drop casting. Subsequently, 40 nm thick source and drain electrodes were deposited on the micro-/nano-crystals by thermal evaporation. Electrical characteristics of the devices were tested with a Keithley 4200-SCS semiconductor parameter analyzer and a Micromanipulator 6150 probe station in a glove box at room temperature. The mobilities were calculated from the saturation region with the following equation: IDS=(W/2L)Ciμ(VG−FT)2, where IDS is the drain-source current, W is the channel width, L is the channel length, μ is the field effect mobility, Ci is the capacitance per unit area of the gate dielectric layer and VG and VT are the gate voltage and threshold voltage, respectively. This equation defines the important characteristics of electron mobility (μ), on/off ratio (Ion/off) and threshold voltage (VT), which could be deduced from the equation using the current voltage plot.
Table 2 provides Field-effect electron (e) and hole (h) mobilities of four OFET devices with different_crystal planes.
indicates data missing or illegible when filed
OLED device fabrication and characterization: The ITO-covered glass slides were cleaned with detergent water, acetone and ethanol each for 30 min by sonication, and finally blown dry with high-purity nitrogen gas. Before deposition of emission layer, ZnMgO nanoparticles dispersed in n-butyl alcohol (40 mg/ml) were spin-coated on ITO substrate, and treated at 120° C. for 15 min. After, SFIC dissolved in chloroform (2 mg/ml) was spin-coated onto ZnMgO-coated ITO glass, followed by annealing at 80° C. for 2 min. The device fabrication process was completed by depositing CBP, MoO3 and Au layers in thermal evaporation chamber with a vacuum pressure below 4×10−4 Pa. The current-voltage characteristics were measured with a computer controlled Keithley 2400 source meter. Electroluminescence spectra were collected using a photonic multichannel analyzer PMA-12 (Hamamatsu C10027-01). The external quantum efficiency of the devices (calculated in the range of 380-780 nm) was obtained by measuring the light intensity in the forward direction using an integrating sphere (Hamamatsu A10094). All the measurements were carried out under ambient atmosphere at room temperature.
Table 3 provides a Summary of optical and electronic properties of SFIC.
indicates data missing or illegible when filed
α λmax was measured in CHCl3 solution. b Amax was measured in film. c Estimated from the onset potential of the first reduction wave and calculated according to ELUMO=−(4.4+Eonsetre) eV. d Estimated from the onset potential of the first oxidation wave and calculated according to EHOMO=−(4.4+Eonset ox) eV. e Eg-E (eV) calculated according to Eg-E=(ELUMO−EHOMO) eV. f Obtained from the edge of the absorption spectra in film according to Eg=(1240/λonset).
Multi-scale computational characterization of charge-transport: Atomistic morphologies and charge-transport in bulk SFIC are calculated from Molecular Dynamics (MD) and kinetic Monte Carlo (kMC) simulations, respectively. The initial bulk supercell of SFIC was grown from the duplications of the experimental unit-cell along a, b, c crystallographic directions given in Table 1. A supercell containing a total of 576 SFIC molecules (217,152 atoms) were considered for these simulations. AMBER software with GAFF force-fields for molecular mechanics parameters were employed for all MD simulations. Partial atomic charges of SFIC using RESP were obtained based on the Merz-Singh-Kollman (MSK)scheme from B3LYP/6-31G(d) optimized geometries in the gas-phase (33). In the MD simulations, the supercell was first gradually heated from 0 K to 300 K for 2 ns, while keeping the heavy-atom positions restrained in order to avoid catastrophic changes. It was then relaxed for 2 ns at 300 K using a Langevin thermostat and another 2 ns equilibration run was performed with reduced restraint, with Berendsen barostat to maintain the pressure at 1 atm (34). Finally, all heavy-atom restraints were removed, and a final 20 ns production run was performed. The atomistic morphology seen in
where Jij is the transfer integral, S is the Huang-Rhys factor, S=λi/ℏω is the internal reorganization energy and ℏω is the mode frequency, λout is the external reorganization energy (λ=λin+λout), and ΔEij=Ei−Ej is site-energy difference. A value of 200 meV is used for both ℏω and λout (35). The internal reorganization energies are calculated from: λh=E0(q+)−E0(q0)+E+(q0)−E+(q+) and λe=E0(q−)−E0(q0)+E−(q0)−E−(q−) using B3LYP/6-31G(d). The internal reorganization energies of SFIC are found to be 82 meV for both hole and electron transport, which results in a total λ=282 meV of reorganization energy. The binding energies of the π⋅⋅⋅π, x ⋅⋅⋅x and CH⋅⋅⋅π dimers are calculated using B97D/6-31G(d,p) and from Ebind=Ec−(Ea+Eb), where Ec is the energy of the complex, Ea and Eb are the constituting monomers. Transfer integrals are evaluated using ZINDO method and site-energies are calculated using Thole model, where RESP partial charges are calculated from MSK and atomic polarizabilities are reparametrized from B3LYP/6-31G(d) calculated molecular polarizabilities. kMC simulations are performed for a single hole (or electron) carrier in an electric field (E→) in the equilibrated cell and periodic boundary conditions are imposed (resulting in a charge density of ˜1023m−3). Hole and electron mobilities are calculated from μ=ν. {circumflex over (ϵ)}/E . All DFT calculations are performed in Gaussian09 (36) and all charge-transport calculations and simulations are performed in VOTCA_package (37).
Material properties: Although the noncovalent π⋅⋅⋅π and CH⋅⋅⋅π interactions are weak, the πOF shows excellent stability, as demonstrated by variable-temperature and recycling-test PXRD experiments, and exhibit self-healing properties, in which the parent porosity is recovered upon solvent annealing at room temperature. It also shows near-infrared light emission at 700 nm. Furthermore, πOFs are novel organic porous materials based on noncovalent π⋅⋅⋅π interactions between molecular units. The framework can be disrupted by optical excitation according to its bandgap. Here, we propose to exploit stimuli-responsive drug delivery by using novel organic porous materials based on noncovalent π⋅⋅⋅π interactions for controllable release of drug.
Drug delivery and release applications: Organic porous crystal materials have created numerous opportunities for biomedical applications. COFs are a representative platform for developing organic porous materials with designable structure and properties. Drug loading and delivery takes advantage of the large specific surface area of organic porous materials. Bai et al. reported nanoscale polyimide-based COFs loaded with antitumor drugs and demonstrated considerable therapeutic effect. Besides, depending on the chemical composition and modifications, organic porous materials have demonstrated tunable properties in different application scenarios. For example, targeted drug delivery has been reported by adding targeting ligands on nanoscale COFs. 2D COFs were also developed as photosensitizers or photothermal agents for photodynamic therapy and photothermal therapy, respectively.
Stimuli-responsive delivery of drugs is an effective way to achieve spatially and temporally controlled drug release. In recent years, various stimuli-responsive strategies have been employed, sensitive to external triggers or biological signals. For example, molecular conformational change of liposomes mediated by hyperthermia can accelerate the release of therapeutics. Conventional organic porous materials, such as COFs, are restricted by covalent bonding, so it is difficult to manipulate the drug release process via stimuli signals. πOFs are novel organic porous materials based on π⋅⋅⋅π interactions between molecular units. The framework can be disrupted by optical excitation according to its bandgap. Here, we propose to exploit stimuli-responsive drug delivery by using novel organic porous materials based on π⋅⋅⋅π interactions.
Drug loading capability of SFIC: πOFs can provide a universal platform for drug loading. We investigated the drug loading capability of SFIC by mixing it with an antitumor drug R848, which can drive the polarization of tumor-associated macrophages and control tumor growth. Both SFIC and R848 were dispersed in methanol and the mixture was stirred by ultrasound. The hydrophobic interaction between the drug and SFIC allows the attachment and encapsulation of R848 in porous SFIC. The mixture was centrifuged after stirring and the amount of R848 in supernatant was measured by high performance liquid chromatography (HPLC).
Table 3 exhibits the encapsulation efficiency and drug loading capability with different stirring time The loading capability was 9.8% by simply mixing R848 with SFIC for 10 minutes. Increasing the time of ultrasonic stirring did not show significant influence on the loading capability. We will further explore drug loading methods for πOFs to improve the loading capability. For example, as SFIC can restore its crystalline structure after solvent annealing, R848 will be dissolved in the dichloromethane solution of SFIC and encapsulated in SFIC during the annealing process. Besides, we will also modify the chemical compounds of SFIC molecules to enhance the interaction between drug molecules and SFIC. Both hydrophobic and hydrophilic drugs can be encapsulated in the πOFs with tunable physical/chemical affinity due to the designable structure of the platform.
The encapsulation efficiency and drug loading capability of R848 in SFIC with different ultrasonic stirring time. Data are shown as mean±standard deviations (n=3).
Photothermal effect of SFIC: πOFs can induce photothermal effect due to its strong absorption of light in or close to the near-infrared region. For example, SFIC has the maximum absorption at around 708 nm with its optical bandgap of 1.75 eV. We investigated the photothermal effect of SFIC encapsulated in polyethylene glycol diacrylate (PEGDA) microneedles as shown in
Further Embodiments: Our work is geared towards building upon our previous work on πOF derivatives and developing novel NIR porous materials We can take advantage of spatial dimensionality in molecules and polarity differences of functional building blocks of small molecules. Increasing dimensionality with the use of branched scaffolds will enable us to generate functional structures that combine multiple conjugation pathways. We can vary the topology and molecular features (e.g., polarity and linking of building blocks) of small molecules to achieve desirable optical properties, better packing morphologies, enhanced inter-and intramolecular interactions, and predictable porous properties. We can design the ability to entrap drugs with high payloads and targeting and highly controllability of the drug release to avoid the ‘burst effect’ (important release within the first minutes). As these electronic and optical properties are the basis of NIR porous noncovalent crystalline materials, a clear understanding of structure-property relationships and assembly of in organic subunits can accelerate progress towards exploring efficient NIR porous noncovalent crystalline materials for controllable drug delivery.
We can use the antitumor efficacy of πOF-mediated drug delivery and photothermal therapy. The π⋅⋅⋅π stacking organic frames can collapse via external stimuli to release the drugs loaded in the materials πOFs. Optical excitation can be performed to trigger the drug release from πOFs as well as rendering photothermal therapeutic effects simultaneously. Based on this feature, multiple combinational therapeutics can be developed for cancer therapy. A B16F10 (ATCC® CRL-6475™) melanoma model can be developed in C57BL/6 mice (8-10 weeks old) and can be used to evaluate the antitumor efficacy leveraged by πOF-loaded microneedles (Mater. Horiz., 2020, 7, 3028-3033.). R848 can be encapsulated in SFIC loaded in PEGDA microneedles that can be applied to the tumor site. We can first characterize the light-triggered transdermal delivery of R848 from the microneedle. R848 can alter the tumor microenvironment by driving the polarization of tumor-associated macrophages to an anti-tumorigenic phenotype Flow cytometry can be performed to investigate the phenotype of macrophages before and after the transdermal administration of R848. We can also focus on the thermal effect induced by SFIC in the microneedle. The immunogenic death (ICD) of cancer cells can be studied by testing the expression of an ICD marker calreticulin. Tumor-associated antigens released during immunogenetic death of tumor cells can be engulfed by the anti-tumorigenic macrophages. This process can promote the cytotoxic activity of T cells against tumor cells and promote the efficacy of cancer therapy. The recruitment of cytotoxic T cells can be studied by flow cytometry and histological imaging. The antitumor efficacy can be evaluated by monitoring the tumor volume and mouse survival. The expression of antitumor cytokines can also be tested by enzyme-linked immunosorbent assay.
μOFs can also be used for NIR-triggered insulin administration. The insulin injection is required for people with type 1 and type 2 diabete. Based on patient's blood glucose level, the dose of insulin should be adjusted to ensure efficacy and safety. NIR-triggered insulin administration can provide a convenient way for dose adjustment of insulin. Instead of syringe, microneedles can reduce the irritation of injection and have been developed for insulin delivery in animal models. We can first investigate the insulin encapsulation and release in μOFs. The insulin-πOF complex can be loaded in microneedles for transdermal delivery of insulin. The formulation of insulin-πOF complex and microneedles can be optimized to make sure NIR-triggered insulin release, which can be quantified by ELISA. We can further evaluate the efficacy of the proposed formulation by applying the microneedle to a diabetic mouse model. By monitoring the blood glucose level of the mouse model, the relationship between NIR radiation and insulin doses will be established (
The attached documents provide various examples of the materials and devices described above and methods of synthesis and manufacture.
Astoundingly, PiOF may also have superconducting properties, which could endow the electronics, electrical, and magnetic related industry with a new perspective. In addition, PiOF may also have energy storage applications, such as the electrodes for supercapacitor and Li-ion batteries (or other batteries which use ions as charges, such as Na+ or Mg2+)
The embodiments illustrated and discussed in this specification are intended only to teach those skilled in the art how to make and use the invention. In describing embodiments of the invention, specific terminology is employed for the sake of clarity. However, the invention is not intended to be limited to the specific terminology so selected. The above-described embodiments of the invention may be modified or varied, without departing from the invention, as appreciated by those skilled in the art in light of the above teachings. It is therefore to be understood that, within the scope of the claims and their equivalents, the invention may be practiced otherwise than as specifically described.
This patent application claims priority benefit from U.S. provisional patent application No. 63/229,910, filed on Aug. 5, 2021, the entire content of which is incorporated herein by reference.
This invention was made with government support under Grant Number FA2386-18-1-4094, awarded by the United States Air Force. The government has certain rights in the invention.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2022/074347 | 7/29/2022 | WO |
Number | Date | Country | |
---|---|---|---|
63229910 | Aug 2021 | US |